Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® in Thai Healthy Volunteers

NCT00477126 Phase 1 COMPLETED

To establish bioequivalence of ritonavir generic capsule, with Norvir® as reference drug.

Details

Lead sponsor	The HIV Netherlands Australia Thailand Research Collaboration
Phase	Phase 1
Status	COMPLETED
Enrolment	16
Start date	2007-01
Completion	2007-02

Conditions

• Healthy

Interventions

• GPO ritonavir versus Norvir

Primary outcomes

• Establish bioequivalence of generic GPO ritonavir, with Norvir® as the reference drug. — 2 months

Countries

Thailand